1,6 For device manufacturers, this price attrition translates into reduced margins, particularly as pharmaceutical companies seek to lower overall therapy costs
We view medical weight loss as a restorative tool for long-term biological health, aiming to prevent the cardiovascular and metabolic risks associated with midlife obesity rather than pursuing a superficial fix
However, the approach differs significantly if you've missed multiple doses or have been off treatment for an extended period
Official Injection Sites for GLP-1 Medications According to their FDA-approved prescribing information, GLP-1 medications semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are administered as injections just under the skin (subcutaneous) in three areas: Abdomen avoid the 2 inches (5 cm) directly around the navel Thigh outer/front thigh Upper arm back of the upper arm All four FDA labels (Ozempic 1 , Zepbound 2 , Mounjaro 3 , Wegovy 4 ) explicitly state that patients should rotate injection sites with each dose
.png)
